Australian man uses ChatGPT to design experimental cancer treatment for his dog

The publication frames the story positively as an example of AI's potential in medical research. It emphasizes the successful outcome while including appropriate scientific caveats from researchers.

The experimental approach appears to have yielded remarkable results. Rosie received a custom mRNA vaccine along with powerful immunotherapy in December, and her cancer is now in partial remission with her largest tumor showing dramatic shrinkage.

She regained a lot of mobility and function

Paul Conyngham — Straits Times

The story has captured international attention, with OpenAI CEO Sam Altman calling it an amazing story on social media platform X. However, the researchers involved emphasize the experimental nature of the treatment and caution against viewing it as a definitive cure.

This was not a clinical trial by any means

Martin Smith, Professor — Straits Times

Professor Martin Smith from UNSW, who sequenced Rosie's genome, credits Conyngham's determination as the driving force behind the project. He notes that the combination of genome sequencing, artificial intelligence, and RNA therapeutics represents a convergence of disruptive technologies that offers new possibilities for medical research.

The case highlights AI's potential to accelerate medical research and democratize access to cutting-edge scientific tools. Conyngham and Rosie have resumed their long daily walks, a testament to the dog's improved condition and her owner's unwavering dedication to finding innovative solutions through technology.